107 related articles for article (PubMed ID: 16118015)
1. Influence of polysaccharide coating on the interactions of nanoparticles with biological systems.
Lemarchand C; Gref R; Passirani C; Garcion E; Petri B; Müller R; Costantini D; Couvreur P
Biomaterials; 2006 Jan; 27(1):108-18. PubMed ID: 16118015
[TBL] [Abstract][Full Text] [Related]
2. Physico-chemical characterization of polysaccharide-coated nanoparticles.
Lemarchand C; Gref R; Lesieur S; Hommel H; Vacher B; Besheer A; Maeder K; Couvreur P
J Control Release; 2005 Nov; 108(1):97-111. PubMed ID: 16169626
[TBL] [Abstract][Full Text] [Related]
3. Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush.
Labarre D; Vauthier C; Chauvierre C; Petri B; Müller R; Chehimi MM
Biomaterials; 2005 Aug; 26(24):5075-84. PubMed ID: 15769543
[TBL] [Abstract][Full Text] [Related]
4. Novel polyester-polysaccharide nanoparticles.
Lemarchand C; Couvreur P; Besnard M; Costantini D; Gref R
Pharm Res; 2003 Aug; 20(8):1284-92. PubMed ID: 12948027
[TBL] [Abstract][Full Text] [Related]
5. Effect of poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles.
Gaucher G; Asahina K; Wang J; Leroux JC
Biomacromolecules; 2009 Feb; 10(2):408-16. PubMed ID: 19133718
[TBL] [Abstract][Full Text] [Related]
6. A biomimetic alternative to poly(ethylene glycol) as an antifouling coating: resistance to nonspecific protein adsorption of poly(L-lysine)-graft-dextran.
Perrino C; Lee S; Choi SW; Maruyama A; Spencer ND
Langmuir; 2008 Aug; 24(16):8850-6. PubMed ID: 18616303
[TBL] [Abstract][Full Text] [Related]
7. Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide.
Bertholon I; Vauthier C; Labarre D
Pharm Res; 2006 Jun; 23(6):1313-23. PubMed ID: 16715369
[TBL] [Abstract][Full Text] [Related]
8. Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption.
Al-Hanbali O; Rutt KJ; Sarker DK; Hunter AC; Moghimi SM
J Nanosci Nanotechnol; 2006; 6(9-10):3126-33. PubMed ID: 17048527
[TBL] [Abstract][Full Text] [Related]
9. Novel core(polyester)-shell(polysaccharide) nanoparticles: protein loading and surface modification with lectins.
Rodrigues JS; Santos-Magalhães NS; Coelho LC; Couvreur P; Ponchel G; Gref R
J Control Release; 2003 Sep; 92(1-2):103-12. PubMed ID: 14499189
[TBL] [Abstract][Full Text] [Related]
10. Influence of PEG chain on the complement activation suppression and longevity in vivo prolongation of the PCL biomedical nanoparticles.
Shan X; Yuan Y; Liu C; Tao X; Sheng Y; Xu F
Biomed Microdevices; 2009 Dec; 11(6):1187-94. PubMed ID: 19609680
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly (ethylene glycol) and polycaprolactone.
Zhang Y; Zhuo RX
Biomaterials; 2005 Nov; 26(33):6736-42. PubMed ID: 15935469
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable nanoparticles made from polylactide-grafted dextran copolymers.
Nouvel C; Raynaud J; Marie E; Dellacherie E; Six JL; Durand A
J Colloid Interface Sci; 2009 Feb; 330(2):337-43. PubMed ID: 19022457
[TBL] [Abstract][Full Text] [Related]
13. A new generation of polymer nanoparticles for drug delivery.
Chauvierre C; Vauthier C; Labarre D; Couvreur P; Marden MC; Leclerc L
Cell Mol Biol (Noisy-le-grand); 2004 May; 50(3):233-9. PubMed ID: 15209344
[TBL] [Abstract][Full Text] [Related]
14. Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy.
Xu P; Van Kirk EA; Li S; Murdoch WJ; Ren J; Hussain MD; Radosz M; Shen Y
Colloids Surf B Biointerfaces; 2006 Mar; 48(1):50-7. PubMed ID: 16497489
[TBL] [Abstract][Full Text] [Related]
15. Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules.
Mosqueira VC; Legrand P; Gulik A; Bourdon O; Gref R; Labarre D; Barratt G
Biomaterials; 2001 Nov; 22(22):2967-79. PubMed ID: 11575471
[TBL] [Abstract][Full Text] [Related]
16. Microbial bioavailability of covalently bound polymer coatings on model engineered nanomaterials.
Kirschling TL; Golas PL; Unrine JM; Matyjaszewski K; Gregory KB; Lowry GV; Tilton RD
Environ Sci Technol; 2011 Jun; 45(12):5253-9. PubMed ID: 21609011
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle DNA carrier with poly(L-lysine) grafted polysaccharide copolymer and poly(D,L-lactic acid).
Maruyama A; Ishihara T; Kim JS; Kim SW; Akaike T
Bioconjug Chem; 1997; 8(5):735-42. PubMed ID: 9327139
[TBL] [Abstract][Full Text] [Related]
18. Shell-sheddable micelles based on dextran-SS-poly(epsilon-caprolactone) diblock copolymer for efficient intracellular release of doxorubicin.
Sun H; Guo B; Li X; Cheng R; Meng F; Liu H; Zhong Z
Biomacromolecules; 2010 Apr; 11(4):848-54. PubMed ID: 20205476
[TBL] [Abstract][Full Text] [Related]
19. Surface coating-dependent cytotoxicity and degradation of graphene derivatives: towards the design of non-toxic, degradable nano-graphene.
Li Y; Feng L; Shi X; Wang X; Yang Y; Yang K; Liu T; Yang G; Liu Z
Small; 2014 Apr; 10(8):1544-54. PubMed ID: 24376215
[TBL] [Abstract][Full Text] [Related]
20. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
Sant S; Poulin S; Hildgen P
J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
